Collaboration combines expertise in computational chemistry, artificial intelligence and machine learning, to help advance discovery and development of medicines for difficult-to-drug targets
Odyssey Therapeutics, Inc., a biotechnology company pioneering next-generation precision medicines, announced it has entered into a strategic research collaboration with Janssen Pharmaceutical NV, a Johnson & Johnson company, to...
Anivive Lifesciences, is set to unveil groundbreaking research at the upcoming World Vaccine Congress, where they will present findings on the development of the world's first systemic antifungal vaccine – A solution for both ends of the leash. The conference, taking place April 1-4, brings together leading experts and researchers from...
Manifold, an AI-powered clinical research platform, announced a $15 million Series A. Led by TQ Ventures, the funding round also includes new investors Calibrate Ventures and SK Ventures, notable founders and CEOs including healthcare leader Dr. Sachin H. Jain and existing investors including TTCER Partners. Built by industry veterans, Manifold's platform streamlines...
PhenoScope can cut drug development time and costs significantly, while delivering safer & more effective therapy for cancer patients
SimBioSys, a leading innovator in precision oncology, and General Inception (“GI”), a global company Igniter, announced a strategic partnership that aims to significantly reduce oncology drug development times and cut development...
Aurigene Pharmaceutical Services Limited , a contract research, development, and manufacturing services organization and a Dr. Reddy’s Laboratories company, introduces Aurigene.AI, an AI and ML-assisted platform for accelerating drug discovery projects from hit identification to candidate nomination.
Aurigene.AI combines advanced physics-based simulation, generative and predictive AI models, and CADD (Computer-Aided...
Ultivue, a market leader in quantitative proteomic biomarker detection and advanced spatial tissue profiling, is unveiling its spatial insights platform, STARVUE™, at the American Association for Cancer Research (AACR) Annual Meeting. STARVUE™ is the culmination of Ultivue's multi-year engineering efforts to bring the latest innovations in artificial intelligence and image data...
X-Chem, the leading provider of innovative solutions in early-stage drug discovery, announced the addition of Dr. Erin Davis as chief technology officer. Dr. Davis brings extensive experience in the areas of data strategy, informatics, computational chemistry and software solutions in drug discovery. The addition of Dr. Davis to X-Chem’s...
Zephyr AI, Inc. a healthcare technology company committed to developing fast and explainable artificial intelligence (AI) solutions to democratize precision medicine, announced the appointment of Rachael Brake, PhD, as its new Chief Scientific Officer.
“Having spent decades working in big pharma and biotech spanning roles in research, development and commercial,...
Intelligencia AI, a provider of AI-powered solutions that support data-driven decision-making in drug development, announced that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,948,667 on April 2, 2024.
The patent titled,"System and Interfaces for Processing and Interacting With Clinical Data,” pertains to the company's novel techniques for training...
Agilent Technologies Inc. announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.
The Agilent ADS 2 is an intelligent autodilutor designed to enhance laboratory workflows. Designed to...
